3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Multiple Myeloma
3
Triple Negative Breast Neoplasms
2
Lymphoma, Non-Hodgkin
2
Breast Neoplasms
2
rrCLL
1
Recurrence
1
Pancreatic Neoplasms
1
Neoplasms
1
Leukemia, Myeloid, Acute
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia, B-Cell
1
Breast Neoplasms, Male
1
Advanced Malignant Solid Neoplasm
1
Interventions
pembrolizumab
1
dinaciclib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
rrCLL
×
dinaciclib
×
Clear all
NCT02684617
2021-03-01
KEYNOTE-155
Merck Sharp & Dohme LLC
Phase 1
Terminated
75 enrolled
17 charts